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We report here a rare case of mesenteric Castleman's
disease presenting as a mesenteric mass. A 13-year-old female
child was admitted to our hospital complaining of intermittent
vague abdominal pain. She had hypochromic anemia, thrombo-
cytosis and an elevated erythrocyte sedimentation rate (ESR).
Ultrasonography and computed tomography indicated an intra-
abdominal mass might represent a lymphoma or gastroin-
testinal stromal tumor or leiomyoma, but the definitive preo-
perative diagnosis couldn't be confirmed. The surgical resec-
tion of the mass revealed the mesenteric hyaline vascular- type
Castleman's disease.
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INTRODUCTION
Castleman's disease is rare lymphoproliferative
disorder stemming from an unknown etiology,
and it is characterized by giant lymph node
hyperplasia and a non-malignant course. This
disease usually occurs in the mediastinum, lung,
neck, axilla, pelvis and retroperitoneum, but mes-
enteric Castleman's disease is very rarely seen.
The clinical presentation is varied, the diagnosis
is difficult and optimum management is still un-
known. We report here our experience of mesen-
teric Castleman's disease in a 13-year old female
child.
CASE REPORT
A 13-years old female child was admitted to the
Korea University Guro Hospital presenting with
intermittent left lower quadrant abdominal pain.
On the physical examination, there was 5-cm
sized palpable mass at the left lower abdominal
quadrant, and the abdomen was without ten-
derness. The initial laboratory testing showed
anemia (a hemoglobin level of 9.6g/dl and a
hematocrit of 29.9%), thrombocytosis (platelet:
874K/ l) and an elevated erythrocyte sedimen μ -
tation rate (ESR) of 130 mm/hr. The chest X-ray
is normal. Abdominal ultrasonography revealed a
3.2×4 cm sized hypoechoic mass lesion with focal
peripheral vascularity (Fig. 1). No organomegaly
was observed, and further investigations showed
the normal level of gammaglobulin. The radio-
logist thought this mass might be a gastroin-
testinal stromal tumor (GIST) or a lymphoma. To
gather more information, a computerized tomo-
graphy (CT) scan was performed. The CT scan
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Fig. 1. Ultrasonography of the patient shows hypoecho-
city with small focal peripheral vascularity.Sung-Hoon Kim, et al.
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revealed a well circumscribed 4×3.5 cm sized,
soft-tissue density, lobulated round mass in the
mid-abdominal cavity (Fig. 2). With the CT scan
findings, this mass was suspected to be a small
bowel stromal tumor, Castleman's disease or
lymphoma; therefore, we opted for surgery to get
the definite diagnosis and treatment. On the
operative field, the egg shaped mass was located
at the root of the small bowel mesentery and it
measured 5.0×4.5×4.0 cm in size. It was hard and
surrounded by a thin fibrous capsule (Fig. 3A). On
sectioning, the cut surface showed as a well
defined homogenous brownish mass with multi-
focal whitish foci (Fig. 3B). On histopathologic
examination, this mass showed lymphoid follicles
separated by bands of connective tissue with
centrally located thickened blood vessels, and it
was compatible with the hyaline vascular type of
Castleman's disease (Fig. 4A, 4B). The patient had
an uneventful postoperative course. Her anemia,
Fig. 3. A. Macroscopically, the mass was egg shaped, and it measured 5.0×4.5×4.0 cm in size. B. The cut surface showed
a well defined homogenous brownish mass with multifocal whitish foci.
Fig. 4. A. On histopathologic examination, lymphoid follicles with centrally located, thick blood vessels and interfollicular
nodular hyalinizing fibrosis (hematoxylin and eosin, 100×). B. A lymphoid follicle containing centrally located blood
vessels with deposits of hyalin (hematoxylin and eosin, 200 ×).
Fig. 2. CT scan of the patient shows a well-circumscribed
intra-abdominal mass of soft tissue density at the small
bowel mesentery.
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thrombocytosis and increased ESR all improved
at the 3-month follow up.
DISCUSSION
Castleman's disease was first described by Dr.
Benjamin Castleman in 1956 when he described a
group of patients with large thymoma-like masses
in the anterior mediastinum.
1 Although it usually
involves the mediastinum, extrathoracic lesion
have been reported in the neck, axilla, shoulder
region, pelvis, pancreas, nasopharynx and retrope-
ritoneum, but finding Castleman's disease located
in mesentery is a very rare event.
The etiology of Castleman's disease is un-
known, but there are several hypotheses involving
chronic low-grade inflammation, a hamartoma-
tous process, an immunodeficiency state and auto-
immunity disorder that have been proposed as
likely pathogenetic machanisms.
1-4
Castleman's disease can be classified into two
types. The first is designated as the hyaline-vas-
cular or angiofollicular type, and it shows small
hyaline follicles and intrafollicular capillary pro-
liferation. This type is present in 90% of the
patients with Castleman's disease and it is gen-
erally seen in the localized cases, and it may
present with fever and fatigue, but it is usually
asymptomatic.
The other type is the plasma cell type, which
less common than the hyaline-vascular type. This
plasma cell type is systemic, symptomatic and
characterized by fever, sweating, weight loss,
anemia, an elevated sedimentation rate and
hypergammaglobulinemia.
5
The radiologic findings of Castleman's disease
are non-specific, and the radiologic study without
a pathologic report is not enough for a definite
diagnosis. Computer assisted tomographic scan
will show a well-defined soft tissue density, and
the hyaline vascular type is more contrast-en-
hanced than the plasma cell type.
6 Magnetic
resonance imaging (MRI) shows a low intensity
mass on T-1 weighted images and a higher signal
intensity on T-2 weighted images.
7 The differential
diagnosis to distinguish it from lymphoma, leio-
myoma, and leiomyosarcoma must be performed.
Surgery is the choice of treatment, and it is also
necessary for diagnosis in localized Castleman's
disease. Radiation or chemotherapy is may be
helpful for treatment, but it is not curative.
8,9
Because Castleman's disease has a benign pro-
gnosis, if complete resection is difficult, partial
resection may be helpful. Extended surgery for
Castleman's disease is not needed for treatment,
and the physician's extensive pre-operative dia-
gnostic effort is required. This rare and benign
disease should therefore be added to the list of
disease in the differential diagnosis of mesenteric
masses.
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